Chronic fluoxetine reverts CORT-induced Nrf2 pathway changes in cortex and Hippoc in a mouse model of depression; Nrf2 enhances BDNF, but fluoxetine enhances cortical and Hippoc BDNF through both Nrf2-dependent and independent pathways. Here, BDNF is linked to depressive symptom measurement.